Sanofi (NASDAQ:SNY) is one of the 11 Best 52-Week Low Stocks to Buy Right Now. On June 30, Sanofi (NASDAQ:SNY) announced that ...

A group from Nagoya University in Japan has developed a simple, accurate, and sensitive method for measuring polysialic acid, ...

Asahi Kasei Pharma begins phase III study of promising CIPN prevention therapy, Recomodulin to enhance treatment options worldwide: Chelmsford, Massachusetts Thursday, July 3, 202 ...

Sanofi's antibody riliprubart has received orphan drug designation from Japan's MHLW for its potential to treat CIDP.

Explore the latest on VYVGART HYTRULO's FDA safety signal and transition challenges. Learn why argenx's balanced risks keep ...

The study is intended to focus on diagnostics and treatment of Lyme IACI symptoms and not to improve diagnostics and treatment for acute Lyme disease. As such, the prevention of Lyme disease ...

Cancer treatment may end, but recovery is a continuing journey. From managing fatigue and nerve pain to rebuilding strength ...

Ferraro MC, Cashin AG, Wand BM, Smart KM, Berryman C, Marston L, Moseley GL, McAuley JH, O'Connell NE. Interventions for treating pain and disability in adults with complex regional pain syndrome- an ...

Both hand cooling and hand compression reduced the incidence of grade 2 or higher chemotherapy-induced peripheral neuropathy ...

Argenx (NASDAQ: ARGX) is one of the best biotech stocks to invest in now. On June 20, Argenx announced that the European ...

This month’s cover story, entitled “Dubious Treatments, ‘Snake Oil Salesmen’ Grab Attention in Rheumatology,” features a stellar lineup of discussants, including Adam Brown, MD; Allan ...